The current UK listing criteria for SPK in a potential T2DM recipient includes; 1) the need for insulin treatment and dependence 2) a BMI of ≤30 kg/m2 and 3) patients must be receiving dialysis or have a GFR ≤20 mLs/min [8]. The gene discussed is INS; the disease is type 2 diabetes mellitus.